Lyell Immunopharma, Inc. (LYEL) Earnings Per Share (EPS)
Lyell Immunopharma, Inc. (LYEL) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$36.80 |
| 2022-12-31 | -$14.80 |
| 2023-12-31 | -$18.60 |
| 2024-12-31 | -$26.20 |
| 2025-12-31 | -$16.06 |
How LYEL compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| CELC | Celcuity Inc. | -$3.79 |
| NTLA | Intellia Therapeutics Inc. | -$3.81 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| BHVN | Biohaven Ltd. | -$6.86 |
| QDEL | QuidelOrtho Corp Com | -$16.69 |
These are five companies in the same sector as LYEL with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Lyell Immunopharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("LYEL")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LYEL | $14.33 | -2.58% | 0.20M |
| 3 | ||||
| 4 | ||||
| 5 |